These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30425580)

  • 21. Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.
    Zhou D; Liang J; Xu LI; He F; Zhou Z; Zhang Y; Chen M
    Oncol Lett; 2016 May; 11(5):2987-2994. PubMed ID: 27123051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
    Zhou X; Sun X; Zhao W; Fang X; Wang X
    Cancer Manag Res; 2019; 11():4243-4254. PubMed ID: 31190991
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
    Su S; Liu L; Li C; Zhang J; Li S
    Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
    Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
    Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer.
    Wang P; Yue W; Li W; Luo Y; Li Z; Shao Y; He Z
    Cancer Manag Res; 2019; 11():813-819. PubMed ID: 30697073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients.
    Qiu X; Song Y; Cui Y; Liu Y
    IUBMB Life; 2018 Jun; 70(6):529-535. PubMed ID: 29707892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.
    Grenader T; Nash S; Adams R; Kaplan R; Fisher D; Maughan T; Bridgewater J
    Br J Cancer; 2016 Mar; 114(6):612-5. PubMed ID: 26889974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
    Troppan K; Deutsch A; Gerger A; Stojakovic T; Beham-Schmid C; Wenzl K; Neumeister P; Pichler M
    Br J Cancer; 2014 Jan; 110(2):369-74. PubMed ID: 24357794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
    Pang J; Wang S; Liao L; Liu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer.
    Yucel S; Bilgin B
    J Oncol Pharm Pract; 2021 Jan; 27(1):71-77. PubMed ID: 32248739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients.
    Azab B; Amundson JR; Cioci A; Stuart H; Yakoub D; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Breast Care (Basel); 2021 Feb; 16(1):43-49. PubMed ID: 33716631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
    Chen XQ; Xue CR; Hou P; Lin BQ; Zhang JR
    World J Gastroenterol; 2019 Sep; 25(33):4970-4984. PubMed ID: 31543687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide.
    Sun W; Li C; Liu M; Liu W; Yang C; Cai LI
    Oncol Lett; 2016 Mar; 11(3):2320-2326. PubMed ID: 26998170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
    Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
    Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
    Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
    Bozkurt O; Karaca H; Berk V; Inanc M; Ocak Duran A; Ozaslan E; Ucar M; Ozkan M
    J BUON; 2015; 20(6):1432-9. PubMed ID: 26854438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning.
    Chen H; Wu S; Hu J; Zhang K; Hu K; Lu Y; He J; Pan T; Chen Y
    J Oncol; 2021; 2021():6641421. PubMed ID: 34054955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: A meta-analysis.
    Duan J; Pan L; Yang M
    Medicine (Baltimore); 2018 Dec; 97(49):e13340. PubMed ID: 30544398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.